
Transcat, Inc. (NASDAQ:TRNS – Free Report) – Investment analysts at Northland Capmk decreased their Q3 2026 earnings per share (EPS) estimates for shares of Transcat in a report issued on Tuesday, November 4th. Northland Capmk analyst E. Jackson now expects that the scientific and technical instruments company will earn $0.26 per share for the quarter, down from their prior forecast of $0.34. Northland Capmk currently has a “Strong-Buy” rating on the stock. The consensus estimate for Transcat’s current full-year earnings is $2.30 per share. Northland Capmk also issued estimates for Transcat’s FY2026 earnings at $1.75 EPS, FY2028 earnings at $2.07 EPS, FY2029 earnings at $2.95 EPS and FY2030 earnings at $3.50 EPS.
Several other analysts also recently commented on the stock. HC Wainwright reissued a “buy” rating and issued a $116.00 target price on shares of Transcat in a research report on Friday, August 22nd. Northland Securities set a $95.00 price objective on shares of Transcat in a research note on Thursday, October 23rd. Weiss Ratings reissued a “hold (c-)” rating on shares of Transcat in a research report on Wednesday. Finally, Zacks Research raised Transcat from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 7th. Two analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $110.25.
Transcat Stock Down 4.6%
TRNS opened at $55.35 on Thursday. The company has a market capitalization of $515.81 million, a PE ratio of 38.71 and a beta of 0.71. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.92 and a quick ratio of 2.36. Transcat has a fifty-two week low of $55.19 and a fifty-two week high of $112.94. The business has a 50-day moving average of $72.92 and a 200-day moving average of $79.44.
Transcat (NASDAQ:TRNS – Get Free Report) last issued its earnings results on Monday, November 3rd. The scientific and technical instruments company reported $0.44 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.02). Transcat had a net margin of 4.64% and a return on equity of 6.66%. The company had revenue of $82.27 million for the quarter, compared to analyst estimates of $79.51 million.
Hedge Funds Weigh In On Transcat
Institutional investors and hedge funds have recently bought and sold shares of the stock. Riverbridge Partners LLC grew its position in Transcat by 94.3% in the 2nd quarter. Riverbridge Partners LLC now owns 440,747 shares of the scientific and technical instruments company’s stock worth $37,887,000 after purchasing an additional 213,927 shares during the last quarter. Conestoga Capital Advisors LLC lifted its stake in shares of Transcat by 13.7% in the second quarter. Conestoga Capital Advisors LLC now owns 1,088,471 shares of the scientific and technical instruments company’s stock valued at $93,565,000 after buying an additional 131,217 shares during the period. T. Rowe Price Investment Management Inc. grew its position in Transcat by 17.1% during the first quarter. T. Rowe Price Investment Management Inc. now owns 607,360 shares of the scientific and technical instruments company’s stock worth $45,218,000 after buying an additional 88,763 shares in the last quarter. Bessemer Group Inc. increased its stake in Transcat by 35.8% during the second quarter. Bessemer Group Inc. now owns 244,491 shares of the scientific and technical instruments company’s stock valued at $21,016,000 after acquiring an additional 64,422 shares during the period. Finally, Neuberger Berman Group LLC increased its stake in Transcat by 5.5% during the first quarter. Neuberger Berman Group LLC now owns 921,898 shares of the scientific and technical instruments company’s stock valued at $68,635,000 after acquiring an additional 47,913 shares during the period. Institutional investors own 98.34% of the company’s stock.
Transcat Company Profile
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Featured Stories
- Five stocks we like better than Transcat
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
- What is the MACD Indicator and How to Use it in Your Trading
- CrowdStrike Partners With CoreWeave But Investors Sell the News
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.
